InMode Expects Q3 Revenue Above Estimates

Thursday, Oct 9, 2025 8:02 am ET1min read

InMode expects Q3 revenue to be between $92.5 million and $93 million, above consensus estimates of $88.05 million. The medical technology company is still finalizing its full financial report, but preliminary results show non-GAAP gross margins between 76% and 77%.

InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, has announced its expectations for the third quarter 2025 financial results. The company is set to release its financial report before the Nasdaq market opens on November 5, 2025, with a conference call scheduled for the same day at 8:30 a.m. Eastern Time InMode to Report Third Quarter 2025 Financial Results and Hold Conference Call on November 5, Expects Q3 Revenue Between $92.5M-$93.0M, Reiterates FY 2025 Guidance Between $365M-$375M[1].

According to preliminary results, InMode expects its revenue for the third quarter of 2025 to be in the range of $92.5 million to $93.0 million. This figure is above the consensus estimates of $88.05 million, indicating a strong performance. The company also expects its non-GAAP gross margin for the quarter to be between 77% and 79%. These figures suggest a robust financial position and operational efficiency InMode to Report Third Quarter 2025 Financial Results and Hold Conference Call on November 5, Expects Q3 Revenue Between $92.5M-$93.0M, Reiterates FY 2025 Guidance Between $365M-$375M[1].

InMode's full-year 2025 revenue is expected to be between $365 million and $375 million, consistent with its prior guidance. This projection aligns with the company's strategic focus on growth and innovation in the medical technology sector InMode to Report Third Quarter 2025 Financial Results and Hold Conference Call on November 5, Expects Q3 Revenue Between $92.5M-$93.0M, Reiterates FY 2025 Guidance Between $365M-$375M[1].

The global general surgery devices market, of which InMode is a significant player, is projected to grow at a CAGR of ~6% by 2032. Factors driving this growth include the increasing volume of surgical procedures, advancements in surgical technology, and a growing preference for minimally invasive surgeries Global General Surgery Devices Market to Register Sustainable Growth at a CAGR of ~6% by 2032 | DelveInsight[2].

InMode's Chief Executive Officer, Moshe Mizrahy, Chief Financial Officer, Yair Malca, and Chief Technology Officer, Dr. Michael Kreindel, will be available to discuss the third quarter 2025 financial results during the conference call. Investors and financial professionals are encouraged to pre-register for the call using the provided link InMode to Report Third Quarter 2025 Financial Results and Hold Conference Call on November 5, Expects Q3 Revenue Between $92.5M-$93.0M, Reiterates FY 2025 Guidance Between $365M-$375M[1].

InMode Expects Q3 Revenue Above Estimates

Comments



Add a public comment...
No comments

No comments yet